Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Baxter
McKinsey
AstraZeneca

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Litigation Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free and ⤷  Try it Free .

Details for BTG INTERNATIONAL LIMITED v. AMNEAL PHARMACEUTICALS LLC,. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-03-08 176 Motion for Miscellaneous Relief Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 by BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
2016-03-08 179 Certificate of Service Hearing And Correct Inventorship of U.S. Patent No. 8,822,438, 178 MOTION to Seal ECF No. 177 (MILLER,… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
2016-03-21 185 Response in Opposition to Motion Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Declaration of Bryan D… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
2016-03-28 187 Reply Brief to Opposition to Motion Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 (Attachments: # 1 Certificate of Service… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
2016-11-10 239 Opinion Tablets (“ZYTIGA®”): United States Patent Nos. 8,822,438 (the “438 patent” …abbreviated as follows: • ‘438 patent = Copy of U.S. Patent No. 8,822,438, Exhibit 1 to the Declaration…partes review (“IPR”) of the ‘438 patent, the Patent Office’s Patent Trial and Appeal Board (“PTAB”) construed… 2 BTG owns the ‘213 patent and Janssen Oncology owns the ‘438 patent. The Janssen plaintiffs are…seeking to add patent infringement claims against certain of the Defendants as to U.S. Patent No. 8,236,946 External link to document
2016-12-16 255 Order Janssen's motion to Correct Inventorship of U.S. Patent No. 8,822,438 35 U.S.C. Sec. 256 at the Post Office Courthouse… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
2016-12-16 256 Order on Motion for Miscellaneous Relief Hearing And Correct Inventorship of U.S. Patent No. 8,822,438 by BTG INTERNATIONAL LIMITED, JANSSEN BIOTECH… 31 July 2015 2:15-cv-05909-KM-JBC Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Express Scripts
McKinsey
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.